live attenuated vaccine against herpes zoster

Developed for: herpes zoster
Investigated by: Beijing Chaoyang District Centre for Disease Control and Prevention

today NCT02526745 · Ph 1/2

201620172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 1/2	NCT02526745	Dec 2015 → Jul 2016	herpes zoster	Beijing Chaoyang District Centre for Disease Control and Prevention	Completed	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	live attenuated vaccine against herpes zoster	“live attenuated vaccine against herpes zoster with high doses of virus content between 4.7～5.0 lgPFU” NCT02526745 ↗
Modality	Vaccine	“live attenuated vaccine against herpes zoster” NCT02526745 ↗